[-] Show simple item record

dc.contributor.authorSaseen, Joseph J.eng
dc.contributor.authorTweed, Elizabeth M.eng
dc.date.issued2006eng
dc.description.abstractMany combination drug therapies are effective in treating dyslipidemia. Compared with statin monotherapy, combinations that include ezetimibe (Zetia), a bile acid sequestrant, or niacin further lower low- density lipoprotein (LDL) cholesterol (strength of recommendation [SOR]: A), and increase the likelihood of attaining National Cholesterol Education Program (NCEP) LDL cholesterol goals (SOR: B). Adding ezetimibe to a bile acid sequestrant reduces LDL cholesterol (SOR: B). Fibrate or niacin added to statin monotherapy provide mixed lipid-modifying effects for combined dyslipidemia (SOR: A).eng
dc.identifier.urihttp://hdl.handle.net/10355/3512eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2006 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 55, no. 01 (January 2006)eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectcombination drug therapyeng
dc.subjectstatinseng
dc.subjectside effectseng
dc.subject.lcshStatins (Cardiovascular Agents)eng
dc.subject.lcshLipids -- Metabolism -- Disorderseng
dc.subject.meshDyslipidemiaseng
dc.titleWhat are effective medication combinations for dyslipidemia?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record